NCT01364428 - Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus | Biotech Hunter

Enrollment

373

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin degludec

"Injected subcutaneously (under the skin) once daily, in combination with unchanged pre-trial oral anti-diabetic drug (OAD) treatment.~Dose was individually adjusted."

DRUG

insulin degludec

"Injected subcutaneously (under the skin) once daily, in combination with unchanged pre-trial oral anti-diabetic drug (OAD) treatment.~Dose was individually adjusted."

Trial Locations (45)

10301

Novo Nordisk Investigational Site, Staten Island

14224

Novo Nordisk Investigational Site, West Seneca

19027

Novo Nordisk Investigational Site, Melrose Park

20852

Novo Nordisk Investigational Site, Rockville

27408

Novo Nordisk Investigational Site, Greensboro

27834

Novo Nordisk Investigational Site, Greenville

30318

Novo Nordisk Investigational Site, Atlanta

33135

Novo Nordisk Investigational Site, Miami

33401

Novo Nordisk Investigational Site, West Palm Beach

33603

Novo Nordisk Investigational Site, Tampa

33765

Novo Nordisk Investigational Site, Clearwater

34201

Novo Nordisk Investigational Site, Bradenton

34741

Novo Nordisk Investigational Site, Kissimmee

35801

Novo Nordisk Investigational Site, Huntsville

37027

Novo Nordisk Investigational Site, Brentwood

37404

Novo Nordisk Investigational Site, Chattanooga

37411

Novo Nordisk Investigational Site, Chattanooga

44718

Novo Nordisk Investigational Site, Canton

45005

Novo Nordisk Investigational Site, Franklin

47714

Novo Nordisk Investigational Site, Evansville

48235

Novo Nordisk Investigational Site, Detroit

62711

Novo Nordisk Investigational Site, Springfield

65109

Novo Nordisk Investigational Site, Jefferson City

68114

Novo Nordisk Investigational Site, Omaha

70002

Novo Nordisk Investigational Site, Metairie

75230

Novo Nordisk Investigational Site, Dallas

75246

Novo Nordisk Investigational Site, Dallas

76054

Novo Nordisk Investigational Site, Hurst

78224

Novo Nordisk Investigational Site, San Antonio

78681

Novo Nordisk Investigational Site, Round Rock

85018

Novo Nordisk Investigational Site, Phoenix

85213

Novo Nordisk Investigational Site, Mesa

85395

Novo Nordisk Investigational Site, Goodyear

91763

Novo Nordisk Investigational Site, Montclair

91950

Novo Nordisk Investigational Site, National City

92262

Novo Nordisk Investigational Site, Palm Springs

94520

Novo Nordisk Investigational Site, Concord

94904

Novo Nordisk Investigational Site, Greenbrae

98057

Novo Nordisk Investigational Site, Renton

98502

Novo Nordisk Investigational Site, Olympia

70461-4231

Novo Nordisk Investigational Site, Slidell

02453-2717

Novo Nordisk Investigational Site, Waltham

08648

Novo Nordisk Investigational Site, Lawrenceville

08755-8050

Novo Nordisk Investigational Site, Toms River

75061-2210

Novo Nordisk Investigational Site, Irving